Latest Tenders From Germany

Open House Discount Contracts 2024-09

Medicine Discount Contracts in Accordance with Section 130A Paragraph 8 Sgb V as Part of Open House Procedures

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

Open Framework Agreement on Drug Discounts in Accordance with Section 130A Paragraph 8 Sgb V with the Possibility of Joining at any Time, So-Called Approval Model 2024-07

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Rivaroxaban (Atc: B01af01 - in all Potencies Except 2.5 Mg Per Divided Oral Dosage...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Rivaroxaban (Atc Code: B01af01).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Rivaroxaban (Atc: B01af01 - with a Potency of 2.5 Mg Per Divided Oral Dosage Form).

Drug Discount Agreements for Various Active Ingredients as Part of an Open House Procedure

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Clobetasol (Atc Code: D07ad01).